Company Filing History:
Years Active: 2022-2025
Title: Todd Herron: Innovator in Cardiomyocyte Research
Introduction
Todd Herron is a notable inventor based in New Hudson, MI (US). He has made significant contributions to the field of cardiomyocyte research, focusing on methods that enhance the maturation of these cells for various applications in drug screening.
Latest Patents
Todd Herron holds 2 patents related to his innovative work. His latest patents include methods for the maturation of cardiomyocytes on amniotic fluid cell-derived extracellular matrix (AFC-ECM). These methods utilize a cell-derived extracellular matrix to mature immature cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs). The patents also describe a cell construct that comprises a monolayer of mature cardiomyocytes on AFC-ECM, which is useful for cardiotoxicity and proarrhythmic screening assays of drug compounds. Additionally, the patents disclose methods for determining the cardiotoxicity and proarrhythmic effects of drug compounds in vitro using these cell constructs.
Career Highlights
Todd Herron is currently associated with Stembiosys, Inc., where he continues to advance his research in cardiomyocyte maturation and drug screening technologies. His work is pivotal in developing safer drug compounds through innovative screening methods.
Collaborations
Some of Todd's notable coworkers include Travis Block and Edward S Griffey, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Todd Herron's work in cardiomyocyte research exemplifies innovation in the field of drug screening and cellular biology. His contributions are vital for the advancement of safer pharmaceutical developments.